Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | E2F8 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SNRPD2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | MSH2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF644 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | LAMC2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | RHOBTB3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | TLR1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | UBE2T | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ARHGEF28 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | CENPW | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |